Gefitinib is an anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis.
Tags :- Gefitinib Manufacturer, Gefitinib Manufacturer in India,Gefitinib Supplier, Supplier in India, Gefitinib Distributor, GefitinibDistributor in India, Gefitinib Merchant Exporter, Gefitinib Exporter,Gefitinib Exporter in India, api, apis, Pharmaceutical Ingredients, ActivePharmaceutical Ingredients, Gefitinib Bulk Drugs manufacturer, Gefitinib BulkDrugs, Gefitinib Bulk drugs in India, Gefitinib Api in India, Bulk Drugs, BulkDrugs in India.